Active

ATRYON BELGIUM

Switched

BE0751698530

Rechtspersoon Besloten Vennootschap 1 establishment

Active for

5 year, 8 months

Registered office

Rue Clément Ader 10

6041 Charleroi

België

Biotech 3

Names & denominations

ATRYON BELGIUM

Official name

FR

Enterprise details

Enterprise type

Rechtspersoon

Legal form

Besloten Vennootschap

Legal situation

Normale toestand

Start date

31 July 2020

Contact

Not specified

Peppol

Active
0208:0751698530

Active since 23 Dec 2025

Powered by

Databakkes.be

Company info. No nonsense.

Activities

NACE-BEL activity descriptions are currently shown in Dutch. English translations are underway.

NACE-BEL activities

What does this company officially do?

82990 Main activity

Overige zakelijke dienstverlening, neg

70200 Main activity

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

70220 Main activity

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overige vormen van onderwijs

What are NACE codes? NACE-BEL is the Belgian version of the European activity nomenclature. Each company has at least one code indicating its main activity.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Clément Ader 10

6041 Charleroi

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Frequently asked questions

What is the enterprise number of ATRYON BELGIUM?
The enterprise number of ATRYON BELGIUM is BE0751698530.
What is the address of ATRYON BELGIUM?
The registered office of ATRYON BELGIUM is located at Rue Clément Ader 10, 6041 Charleroi.
When was ATRYON BELGIUM founded?
ATRYON BELGIUM was founded on 31 July 2020.
What is the main activity of ATRYON BELGIUM?
The main activity of ATRYON BELGIUM is "Overige zakelijke dienstverlening, neg" (NACE code 82990).
Does ATRYON BELGIUM have a website?
No website is currently known for ATRYON BELGIUM.